246 related articles for article (PubMed ID: 34454617)
1. Evaluation of low-pass genome sequencing in polygenic risk score calculation for Parkinson's disease.
Kim S; Shin JY; Kwon NJ; Kim CU; Kim C; Lee CS; Seo JS
Hum Genomics; 2021 Aug; 15(1):58. PubMed ID: 34454617
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Parkinson's Disease Risk Based on Genetic Profile and Established Risk Factors.
Chairta PP; Hadjisavvas A; Georgiou AN; Loizidou MA; Yiangou K; Demetriou CA; Christou YP; Pantziaris M; Michailidou K; Zamba-Papanicolaou E
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440451
[TBL] [Abstract][Full Text] [Related]
3. Validity and Prognostic Value of a Polygenic Risk Score for Parkinson's Disease.
Koch S; Laabs BH; Kasten M; Vollstedt EJ; Becktepe J; Brüggemann N; Franke A; Krämer UM; Kuhlenbäumer G; Lieb W; Mollenhauer B; Neis M; Trenkwalder C; Schäffer E; Usnich T; Wittig M; Klein C; König IR; Lohmann K; Krawczak M; Caliebe A
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946808
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial and autophagy-lysosomal pathway polygenic risk scores predict Parkinson's disease.
Dehestani M; Liu H; Sreelatha AAK; Schulte C; Bansal V; Gasser T
Mol Cell Neurosci; 2022 Jul; 121():103751. PubMed ID: 35710056
[TBL] [Abstract][Full Text] [Related]
5. Association of the Polygenic Risk Score with the Incidence Risk of Parkinson's Disease and Cerebrospinal Fluid α-Synuclein in a Chinese Cohort.
Li WW; Fan DY; Shen YY; Zhou FY; Chen Y; Wang YR; Yang H; Mei J; Li L; Xu ZQ; Wang YJ
Neurotox Res; 2019 Oct; 36(3):515-522. PubMed ID: 31209785
[TBL] [Abstract][Full Text] [Related]
6. Low coverage whole genome sequencing enables accurate assessment of common variants and calculation of genome-wide polygenic scores.
Homburger JR; Neben CL; Mishne G; Zhou AY; Kathiresan S; Khera AV
Genome Med; 2019 Nov; 11(1):74. PubMed ID: 31771638
[TBL] [Abstract][Full Text] [Related]
7. Genotype imputation and variability in polygenic risk score estimation.
Chen SF; Dias R; Evans D; Salfati EL; Liu S; Wineinger NE; Torkamani A
Genome Med; 2020 Nov; 12(1):100. PubMed ID: 33225976
[TBL] [Abstract][Full Text] [Related]
8. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations.
Dai J; Lv J; Zhu M; Wang Y; Qin N; Ma H; He YQ; Zhang R; Tan W; Fan J; Wang T; Zheng H; Sun Q; Wang L; Huang M; Ge Z; Yu C; Guo Y; Wang TM; Wang J; Xu L; Wu W; Chen L; Bian Z; Walters R; Millwood IY; Li XZ; Wang X; Hung RJ; Christiani DC; Chen H; Wang M; Wang C; Jiang Y; Chen K; Chen Z; Jin G; Wu T; Lin D; Hu Z; Amos CI; Wu C; Wei Q; Jia WH; Li L; Shen H
Lancet Respir Med; 2019 Oct; 7(10):881-891. PubMed ID: 31326317
[TBL] [Abstract][Full Text] [Related]
9. Best practices for analyzing imputed genotypes from low-pass sequencing in dogs.
Buckley RM; Harris AC; Wang GD; Whitaker DT; Zhang YP; Ostrander EA
Mamm Genome; 2022 Mar; 33(1):213-229. PubMed ID: 34498136
[TBL] [Abstract][Full Text] [Related]
10. Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.
Paul KC; Schulz J; Bronstein JM; Lill CM; Ritz BR
JAMA Neurol; 2018 Mar; 75(3):360-366. PubMed ID: 29340614
[TBL] [Abstract][Full Text] [Related]
11. Imputation and Reanalysis of ExomeChip Data Identifies Novel, Conditional and Joint Genetic Effects on Parkinson's Disease Risk.
Rodrigo LM; Nyholt DR
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34064523
[TBL] [Abstract][Full Text] [Related]
12. Polygenic Risk Scores Validated in Patient-Derived Cells Stratify for Mitochondrial Subtypes of Parkinson's Disease.
Arena G; Landoulsi Z; Grossmann D; Payne T; Vitali A; Delcambre S; Baron A; Antony P; Boussaad I; Bobbili DR; Sreelatha AAK; Pavelka L; J Diederich N; Klein C; Seibler P; Glaab E; Foltynie T; Bandmann O; Sharma M; Krüger R; May P; Grünewald A;
Ann Neurol; 2024 Jul; 96(1):133-149. PubMed ID: 38767023
[TBL] [Abstract][Full Text] [Related]
13. Association analysis and polygenic risk score evaluation of 38 GWAS-identified Loci in a Chinese population with Parkinson's disease.
Zheng R; Qiao S; Chen Y; Jin C; Fang Y; Lin Z; Xue N; Yan Y; Gu L; Gao T; Tian J; Yan Y; Yin X; Pu J; Zhang B
Neurosci Lett; 2021 Sep; 762():136150. PubMed ID: 34352340
[TBL] [Abstract][Full Text] [Related]
14. The predictive capacity of polygenic risk scores for disease risk is only moderately influenced by imputation panels tailored to the target population.
Levi H; Elkon R; Shamir R
Bioinformatics; 2024 Feb; 40(2):. PubMed ID: 38265251
[TBL] [Abstract][Full Text] [Related]
15. Polygenic risk prediction and SNCA haplotype analysis in a Latino Parkinson's disease cohort.
Loesch DP; Horimoto ARVR; Sarihan EI; Inca-Martinez M; Mason E; Cornejo-Olivas M; Torres L; Mazzetti P; Cosentino C; Sarapura-Castro E; Rivera-Valdivia A; Medina AC; Dieguez E; Raggio V; Lescano A; Tumas V; Borges V; Ferraz HB; Rieder CR; Schumacher-Schuh A; Santos-Lobato BL; Velez-Pardo C; Jimenez-Del-Rio M; Lopera F; Moreno S; Chana-Cuevas P; Fernandez W; Arboleda G; Arboleda H; Arboleda-Bustos CE; Yearout D; Zabetian CP; ; Thornton TA; Mata IF; O'Connor TD;
Parkinsonism Relat Disord; 2022 Sep; 102():7-15. PubMed ID: 35917738
[TBL] [Abstract][Full Text] [Related]
16. The power of TOPMed imputation for the discovery of Latino-enriched rare variants associated with type 2 diabetes.
Huerta-Chagoya A; Schroeder P; Mandla R; Deutsch AJ; Zhu W; Petty L; Yi X; Cole JB; Udler MS; Dornbos P; Porneala B; DiCorpo D; Liu CT; Li JH; Szczerbiński L; Kaur V; Kim J; Lu Y; Martin A; Eizirik DL; Marchetti P; Marselli L; Chen L; Srinivasan S; Todd J; Flannick J; Gubitosi-Klug R; Levitsky L; Shah R; Kelsey M; Burke B; Dabelea DM; Divers J; Marcovina S; Stalbow L; Loos RJF; Darst BF; Kooperberg C; Raffield LM; Haiman C; Sun Q; McCormick JB; Fisher-Hoch SP; Ordoñez ML; Meigs J; Baier LJ; González-Villalpando C; González-Villalpando ME; Orozco L; García-García L; Moreno-Estrada A; ; Aguilar-Salinas CA; Tusié T; Dupuis J; Ng MCY; Manning A; Highland HM; Cnop M; Hanson R; Below J; Florez JC; Leong A; Mercader JM
Diabetologia; 2023 Jul; 66(7):1273-1288. PubMed ID: 37148359
[TBL] [Abstract][Full Text] [Related]
17. Validating and automating learning of cardiometabolic polygenic risk scores from direct-to-consumer genetic and phenotypic data: implications for scaling precision health research.
Lopez-Pineda A; Vernekar M; Moreno-Grau S; Rojas-Muñoz A; Moatamed B; Lee MTM; Nava-Aguilar MA; Gonzalez-Arroyo G; Numakura K; Matsuda Y; Ioannidis A; Katsanis N; Takano T; Bustamante CD
Hum Genomics; 2022 Sep; 16(1):37. PubMed ID: 36076307
[TBL] [Abstract][Full Text] [Related]
18. The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight.
Bandres-Ciga S; Ahmed S; Sabir MS; Blauwendraat C; Adarmes-Gómez AD; Bernal-Bernal I; Bonilla-Toribio M; Buiza-Rueda D; Carrillo F; Carrión-Claro M; Gómez-Garre P; Jesús S; Labrador-Espinosa MA; Macias D; Méndez-Del-Barrio C; Periñán-Tocino T; Tejera-Parrado C; Vargas-González L; Diez-Fairen M; Alvarez I; Tartari JP; Buongiorno M; Aguilar M; Gorostidi A; Bergareche JA; Mondragon E; Vinagre-Aragon A; Croitoru I; Ruiz-Martínez J; Dols-Icardo O; Kulisevsky J; Marín-Lahoz J; Pagonabarraga J; Pascual-Sedano B; Ezquerra M; Cámara A; Compta Y; Fernández M; Fernández-Santiago R; Muñoz E; Tolosa E; Valldeoriola F; Gonzalez-Aramburu I; Sanchez Rodriguez A; Sierra M; Menéndez-González M; Blazquez M; Garcia C; Suarez-San Martin E; García-Ruiz P; Martínez-Castrillo JC; Vela-Desojo L; Ruz C; Barrero FJ; Escamilla-Sevilla F; Mínguez-Castellanos A; Cerdan D; Tabernero C; Gomez Heredia MJ; Perez Errazquin F; Romero-Acebal M; Feliz C; Lopez-Sendon JL; Mata M; Martínez Torres I; Kim JJ; Dalgard CL; ; Brooks J; Saez-Atienzar S; Gibbs JR; Jorda R; Botia JA; Bonet-Ponce L; Morrison KE; Clarke C; Tan M; Morris H; Edsall C; Hernandez D; Simon-Sanchez J; Nalls MA; Scholz SW; Jimenez-Escrig A; Duarte J; Vives F; Duran R; Hoenicka J; Alvarez V; Infante J; Marti MJ; Clarimón J; López de Munain A; Pastor P; Mir P; Singleton A;
Mov Disord; 2019 Dec; 34(12):1851-1863. PubMed ID: 31660654
[TBL] [Abstract][Full Text] [Related]
19. Polygenic risk of Parkinson disease is correlated with disease age at onset.
Escott-Price V; ; Nalls MA; Morris HR; Lubbe S; Brice A; Gasser T; Heutink P; Wood NW; Hardy J; Singleton AB; Williams NM;
Ann Neurol; 2015 Apr; 77(4):582-91. PubMed ID: 25773351
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson's Disease Patients from India.
Kukkle PL; Geetha TS; Chaudhary R; Sathirapongsasuti JF; Goyal V; Kandadai RM; Kumar H; Borgohain R; Mukherjee A; Oliver M; Sunil M; Mootor MFE; Kapil S; Mandloi N; Wadia PM; Yadav R; Desai S; Kumar N; Biswas A; Pal PK; Muthane UB; Das SK; Sakthivel Murugan SM; Peterson AS; Stawiski EW; Seshagiri S; Gupta R; Ramprasad VL; Prai PRAOI
Adv Biol (Weinh); 2022 Nov; 6(11):e2101326. PubMed ID: 35810474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
